- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06206577
Autogenous Grafts for Anterior Maxillary Horizontal Ridge Augmentation
Autogenous Inlay Versus Onlay Grafts for Anterior Maxillary Horizontal Ridge Augmentation
Study Overview
Status
Conditions
Detailed Description
Autogenous block graft has been used as onlay thin cortical shell and cortico-cancellous particles. The thin cortical shell acts as an autogenous biological membrane that will resist resorption and stabilize the small pieces of particulate bone. The bone block is screwed-in at a distance from the recipient site by means of titanium bone screws, and then the free space under the shell is filled with the particulate bone.
The resultant augmentation somehow resembles an iliac graft, with thick internal cancellous bone and a thin external cortical layer. This leads to an ideal graft, with a high regenerative capacity comparable to iliac bone and a stable regenerated volume with optimum osseointegration potential close to that of mandibular block grafts.
Interpositional grafts have been successfully established in restoring vertical bone height . However much less evidence is present on its use for horizontal augmentation. It is the purpose of this study to assess the efficacy of autogenous onlay corticocancellous block grafts for anterior maxillary horizontal ridge augmentation as compared to onlay block grafts.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mansoura, Egypt
- Mansoura U
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with missing upper anterior tooth / teeth with horizontal ridge dimension range from 2 to 5 mm (measured 2mm below alveolar crest).
- Adequate vertical height.
- Having good oral hygiene.
- being healthy, with no systemic diseases that might contraindicate receiving a dental implant
- Patients were able to comply with the follow-up and maintenance program
Exclusion Criteria:
- Presence of local infection or lesions at site of interest.
- Dental history of bruxism, or other parafunctional habits.
- Uncooperative patients.
- Current chemotherapy or radiotherapy.
- Patients with aggressive periodontal disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
Seven horizontal anterior maxillary ridge augmentation was done with symphyseal autogenous bone block, which was placed buccally as onlay graft.
|
autogenous bone block harvested from chin area using piezosurgery and fixed buccally in deficient area with fixation screws
|
|
Experimental: Group B
Seven horizontal anterior maxillary ridge augmentation was done with symphyseal autogenous bone block, which was interpositioned in space created between buccal and lingual cortex as inlay graft.
|
autogenous bone block harvested from chin area using piezosurgery and fixed in bone split created at deficient area with fixation screws
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
horizontal ridge augmentation
Time Frame: 12 months
|
CBCT to assess bone gain in mm
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- A08040820
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alveolar Ridge Augmentation
-
University of Central LancashireImperial College LondonNot yet recruitingAlveolar Ridge AugmentationUnited Kingdom
-
University of Santiago de CompostelaFriedrich-Alexander-Universität Erlangen-NürnbergActive, not recruiting
-
University of LouisvilleCompleted
-
Stony Brook UniversityUnknownAlveolar Ridge AugmentationUnited States
-
Scil Technology GmbHFGK Clinical Research GmbHUnknownAlveolar Ridge AugmentationGermany
-
University of BernCompletedAlveolar Ridge AugmentationSwitzerland
-
Ugur GULSENCompletedAlveolar Ridge Augmentation
-
NIBEC Co., Ltd.RecruitingAlveolar Ridge AugmentationSouth Korea
-
University of Maryland, BaltimoreRecruiting
-
Cliniques universitaires Saint-Luc- Université...Geistlich Pharma AGRecruitingAlveolar Ridge AugmentationBelgium